Advertisement

Molecular and Cellular Biochemistry

, Volume 381, Issue 1–2, pp 85–94 | Cite as

Experimental diabetes treated with trigonelline: effect on key enzymes related to diabetes and hypertension, β-cell and liver function

  • Khaled HamdenEmail author
  • Amel Bengara
  • Zahra Amri
  • Abdelfattah Elfeki
Article

Abstract

Type 2 diabetes is quite diverse, including the improvement of insulin sensitivity by dipeptidylpeptidase-4 (DPP-4) inhibitor, α-glucosidase inhibitors, and the protection of β-cells islet. The aim of this study was to search the effect of trigonelline (Trig) on DPP-4, α-glucosidase and angiotensin converting enzyme (ACE) activities as well as β-cells architecture, and starch and glucose tolerance test. In surviving diabetic rats, the supplement of Trig potentially inhibited DPP-4 and α-glucosidase activities in both plasma and small intestine. The pancreas islet and less β-cells damage were observed after the administration of trig to diabetic rats. The increase of GLP-1 in surviving diabetic rats suppressed the increase of blood glucose level and improved results in the oral glucose and starch tolerance test. Trig also normalized key enzyme related to hypertension as ACE and improved the hemoglobin A1c and lipid profiles (plasma triglyceride, HDL-cholesterol, LDL-cholesterol, and total cholesterol), and liver indices toxicity. Therefore, these results revealed that Trig was successful in improving glycemic control, metabolic parameters, and liver function in diabetic rats. It is therefore suggested that Trig may be a potential agent for the treatment of type 2 diabetes.

Keywords

Trigonelline Diabetes DPP-4 α-Glucosidase ACE Pancreas Rat 

Notes

Acknowledgments

This research was supported by the Tunisian Ministry of Higher Education and Scientific Research and Technology and the Tunisian Ministry of public health.

References

  1. 1.
    Sundaram B, Singhal K, Sandhir R (2012) Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. BioFactors 38:59–68PubMedCrossRefGoogle Scholar
  2. 2.
    Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40PubMedCrossRefGoogle Scholar
  3. 3.
    Schiel R, Müller UA, Beltschikow W, Stein G (2006) Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990–1994/1995). Results of the JEVIN trial. J Diabetes Complicat 20:273–279PubMedCrossRefGoogle Scholar
  4. 4.
    Arda-Pirincci P, Bolkent S (2011) The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant–antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D. Mol Cell Biochem 350:13–27PubMedCrossRefGoogle Scholar
  5. 5.
    Juhl CB, Schmitz O, Pincus S, Holst JJ, Veldhuis J, Pørksen N (2000) Short-term treatment with GLP-1 increases pulsatile insulin secretion in type II diabetes with no effect on orderliness. Diabetologia 43:583–588PubMedCrossRefGoogle Scholar
  6. 6.
    Ahrén B (2007) GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors. Curr Diabetes Rep 7:340–347CrossRefGoogle Scholar
  7. 7.
    Anh Dao TM, Waget A, Klopp P, Serino M, Vachoux C, Pechere L, Drucker DJ, Champion S, Barthe′lemy S, Barra Y, Burcelin R, Seree E (2012) Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control. PLoS ONE doi: 10.1371/journal.pone.0020700
  8. 8.
    Mochida T, Hira T, Hara H (2010) The corn protein, zein hydrolysate, administered into the ileum attenuates hyperglycemia via its dual action on glucagon-like peptide-1 secretion and dipeptidyl peptidase-IV activity in rats. Endocrinology 151:3095–3104PubMedCrossRefGoogle Scholar
  9. 9.
    Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J (2011) Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS ONE 6:16556CrossRefGoogle Scholar
  10. 10.
    Rodriguez-Mateos A, Ishisaka A, Mawatari K, Vidal-Diez A, Jeremy PE, Spencer JPE, Terao J (2012) Blueberry intervention improves vascular reactivity and lowers blood pressure in high-fat-, high-cholesterol-fed rats. doi: 10.1017/S0007114512003911
  11. 11.
    Yuan L, Tu D, Ye X, Wu J (2012) Hypoglycemic and hypocholesterolemic effects of Coptis chinensis franch inflorescence. Adv Nat Sci 3:1–9Google Scholar
  12. 12.
    Chua M, Baldwin TC, Hocking TJ, Chan K (2010) Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E. Br J Ethnopharmacol 128:268–278CrossRefGoogle Scholar
  13. 13.
    Van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, Van Dam RM (2010) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025CrossRefGoogle Scholar
  14. 14.
    State Administration of Traditional Chinese Medicine (1999) Chinese Materia Medica (II). Shanghai Science and Technology Press, Shanghai, pp 748–749Google Scholar
  15. 15.
    Jiangsu New Medical College Compiled (1997) The second volume of dictionary of Chinese medicine. Shanghai People’s Publishing House, Shanghai, pp 2370–2371Google Scholar
  16. 16.
    Moorthy R, Prabhu K, Murthy P (1989) Studies on the isolation and effect of orally active hypoglycemic principle from the seeds of fenugreek (Trigonella foenum graecum). Diabetes Bull 9:69–72Google Scholar
  17. 17.
    Mishkinsky J, Joseph B, Sulman FG (1967) Hypoglycaemic effect of trigonelline. Lancet 2:1311–1312PubMedCrossRefGoogle Scholar
  18. 18.
    van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025PubMedCrossRefGoogle Scholar
  19. 19.
    Olthof MR, van Dijk AE, Deacon CF, Heine RJ, van Dam RM (2011) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr Metab 8:1743–7075CrossRefGoogle Scholar
  20. 20.
    Zhou J, Zhou S, Zeng S (2013) Experimental diabetes treated with trigonelline: effect on β-cell and pancreatic oxidative parameters. Fund Clin Pharmacol 27(3):279–287. doi: 10.1111/j.1472-8206.2011.01022.x CrossRefGoogle Scholar
  21. 21.
    Bakuradze T, Lang R, Hofmann T, Stiebitz H, Bytof G, Lantz I, Baum M, Eisenbrand G, Janzowski C (2010) Antioxidant effectiveness of coffee extracts and selected constituents in cell-free systems and human colon cell lines. Mol Nutr Food Res 54:1734–1743PubMedCrossRefGoogle Scholar
  22. 22.
    Yoshinari O, Igarashi K (2010) Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice. Curr Med Chem 17:2196–2202PubMedCrossRefGoogle Scholar
  23. 23.
    Yoshinari O, Sato H, Igarashi K (2009) Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci Biotechnol Biochem 73:1033–1041PubMedCrossRefGoogle Scholar
  24. 24.
    Pascual I, Lopéz A, Gómez H, Chappé M, Saroyán A, González Y, Cisneros M, Charli JL, Angeles Chávez M (2007) Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms. Enzym Microb Technol 40:414–419CrossRefGoogle Scholar
  25. 25.
    Dahlqvist A (1984) Assay of intestinal disaccharidases. Scand J Clin Lab Investig 44:169–172CrossRefGoogle Scholar
  26. 26.
    Cushman DW, Cheung HS (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20:1637–1648PubMedCrossRefGoogle Scholar
  27. 27.
    Hamden K, Mnafgui K, Belhaj S, Aloulou A, Elfeki A (2013) Inhibition of key digestive enzymes-related to diabetes and hyperlipidemia and protection of liver–kidney functions by trigonelline in diabetic rats. Sci Pharm 81(1):233–246PubMedCrossRefGoogle Scholar
  28. 28.
    Olthof MR, Evan Dijk A, Deacon CF, Heine RJ, van Dam RM (2011) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr Metab 8:10CrossRefGoogle Scholar
  29. 29.
    Puri D, Prabhu KM, Murthy PS (2002) Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Ind J Physiol Pharmacol 46:457–462Google Scholar
  30. 30.
    Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ (2001) Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 224:45–51PubMedCrossRefGoogle Scholar
  31. 31.
    Thakran S, Siddiqui MR, Baquer NZ (2004) Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats. Mol Cell Biochem 266:151–159PubMedCrossRefGoogle Scholar
  32. 32.
    Latha M, Pari L (2004) Effect of an aqueous extract of Scoparia dulcis on blood glucose, plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Br J Med Biol Res 37:577–586CrossRefGoogle Scholar
  33. 33.
    Ghule AE, Jadhav SS, Bodhankar SL (2012) Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats. Int Immunopharmacol 14:740–748PubMedCrossRefGoogle Scholar
  34. 34.
    Hamden K, Jaouadi B, Salami T, Carreau S, Bejar S, Elfeki A (2010) Modulatory effect of fenugreek saponins on the activities of intestinal and hepatic disaccharidase and glycogen and liver function of diabetic rats. Biotechnol Bioprocess Eng 15:745–753CrossRefGoogle Scholar
  35. 35.
    Moore CJ, Shao CH, Nagai R, Kutty S, Singh J, Bidasee KR (2013) Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco (endo) plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes. Mol Cell Biochem 376:121–135Google Scholar
  36. 36.
    Pari L, Karthikesan K, Menon VP (2010) Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol Cell Biochem 341:109–117Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Khaled Hamden
    • 1
    Email author
  • Amel Bengara
    • 2
  • Zahra Amri
    • 2
  • Abdelfattah Elfeki
    • 2
  1. 1.Biotechnology High School of Sfax (ISBS)University of SfaxSfaxTunisia
  2. 2.Laboratory of Animal Ecophysiology, Faculty of Sciences of SfaxUniversity of SfaxSfaxTunisia

Personalised recommendations